James R Broughman
Overview
Explore the profile of James R Broughman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1701
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mayo Z, Halima A, Broughman J, Smile T, Tom M, Murphy E, et al.
J Neurooncol
. 2023 Jan;
161(1):23-31.
PMID: 36633800
Purpose: Cerebral radiation necrosis is a complication of radiation therapy that can be seen months to years following radiation treatment. Differentiating radiation necrosis from tumor progression on standard magnetic resonance...
2.
Blutt S, Crawford S, Bomidi C, Zeng X, Broughman J, Robertson M, et al.
Am J Physiol Gastrointest Liver Physiol
. 2021 Jul;
321(3):G270-G279.
PMID: 34288725
The use of human tissue stem cell-derived organoids has advanced our knowledge of human physiological and pathophysiological processes that are unable to be studied using other model systems. Increased understanding...
3.
Joshi N, Broughman J
Curr Treat Options Oncol
. 2021 Feb;
22(3):23.
PMID: 33560478
Salivary gland tumors represent a heterogeneous group of neoplasms characterized by varied histologies and disease outcomes. Initial treatment for the primary and gross nodal disease is usually surgery. Management of...
4.
Broughman J, Vuong W, Mian O
Curr Treat Options Oncol
. 2020 Nov;
22(1):3.
PMID: 33230599
Although radical cystectomy is considered the gold standard approach for patients with muscle-invasive bladder cancer, tri-modal therapy (TMT) is a well-tolerated and efficacious alternative to radical cystectomy that is underutilized...
5.
Fleming C, Broughman J, Tendulkar R
Curr Treat Options Oncol
. 2020 Nov;
22(1):2.
PMID: 33216272
Due to its relatively indolent disease course, the sensitivity of PSA testing, and the emergence of novel PET imaging, metastatic prostate cancer is particularly likely to present with a limited...
6.
Broughman J, Fleming C, Mian O, Stephans K, Tendulkar R
Appl Radiat Oncol
. 2020 Nov;
9(3):6-10.
PMID: 33134438
No abstract available.
7.
Contrera K, Smile T, Mahomva C, Wei W, Adelstein D, Broughman J, et al.
Oral Oncol
. 2020 Oct;
111:105030.
PMID: 33038751
Introduction: The objective of this study is to evaluate locoregional and distant failure for human papillomavirus-associated (HPV+) oropharyngeal squamous cell carcinoma (OPSCC) using American Joint Committee on Cancer eighth edition...
8.
Broughman J, Xiong D, Moeller B, Contrera K, Prendes B, Lamarre E, et al.
Cancer
. 2020 Mar;
126(12):2784-2790.
PMID: 32167593
Background: De-intensified treatment strategies for early human papillomavirus-positive (HPV+) oropharynx cancer (OPC) rely on selecting patients with an excellent prognosis. The criterion for enrollment in current de-intensification trials is ≤10...
9.
Ericson K, Murthy P, Bryk D, Ramkumar R, Broughman J, Khanna A, et al.
Clin Adv Hematol Oncol
. 2019 Dec;
17(12):697-707.
PMID: 31851158
Bladder-sparing therapies for the treatment of nonmetastatic muscle-invasive bladder cancers are included in both American and European guidelines. Numerous treatment approaches have been described, including partial cystectomy, radiation monotherapy, and...
10.
Crawford S, Criglar J, Liu Z, Broughman J, Estes M
J Virol
. 2019 Oct;
94(1).
PMID: 31597778
Many viruses that replicate in the cytoplasm dramatically remodel and stimulate the accumulation of host cell membranes for efficient replication by poorly understood mechanisms. For rotavirus, a critical step in...